Belpointe Asset Management’s AVEO Pharmaceuticals AVEO Stock Holding History
Bought
Maintained
Sold
Belpointe Asset Management's AVEO Position: Q1 2023 in Review
Belpointe Asset Management sold out of AVEO Pharmaceuticals (AVEO) in Q1 2023, closing a stake of 1,000 shares — an estimated $15K sold.
Belpointe Asset Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $15K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Belpointe Asset Management reported no remaining AVEO Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
- Belpointe Asset Management sold 1,000 AVEO Pharmaceuticals shares in Q1 2023, an estimated $15K.
- Belpointe Asset Management first reported a position in AVEO Pharmaceuticals in Q4 2022 and held it in 1 quarter.
- Belpointe Asset Management's AVEO Pharmaceuticals position peaked at $15K in Q4 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals as of Q1 2023.
Based on Belpointe Asset Management's 13F filing for Q1 2023, filed 15 May 2023.